CG Oncology (CGON) Income Statement

CG Oncology reported revenue of $4.04M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 254.7% from $1.14M a year earlier. CG Oncology posted a net loss of $161.00M, compared with a net loss of $88.04M a year earlier. Gross margin was -15.0% and operating margin -4722.1%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $1.16M.

CG Oncology Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

CG Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	4.04	1.14	0.20	0.19	10.36
Cost of Revenue	121.29	82.10	45.75	29.03	18.32
Gross Profit	-0.61	1.14	0.20	0.19	10.36
Operating Expenses
Research & Development	116.64	82.10	45.75	29.03	18.32
Selling, General & Administrative	73.53	33.70	9.90	6.41	4.65
Operating Expenses	190.17	115.81	55.65	35.44	22.96
Operating Income	-190.77	-114.67	-55.45	-35.25	-12.61
Other Income/Expense
Interest Income	29.93	26.62	6.90	1.60	0.00
Interest Expense	0.00	0.00	0.00	0.00	-0.45
Other Income/Expense	29.78	26.63	-0.06	-0.20	-0.23
Income
Income Before Tax	-161.00	-88.04	-48.61	-35.44	-12.84
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-161.00	-88.04	-48.61	-43.79	-18.38
Net Income - Continuous Operations	-161.00	-88.04	-48.61	-35.44	-12.84
Net Income - Discontinued Operations	-	-	-	-	-
EBITDA	-189.33	-114.63	-55.43	-35.23	-12.60
EBIT	-190.77	-114.67	-55.45	-35.25	-12.61
Depreciation & Amortization	1.45	0.03	0.02	0.02	0.01
Earnings Per Share
Basic EPS	-2.00	-1.00	-16.00	-12.00	-5.00
Diluted EPS	-2.00	-1.00	-16.00	-12.00	-5.00
Basic Shares Outstanding	77.30	62.50	4.33	3.74	3.65
Diluted Shares Outstanding	77.30	62.50	4.33	3.74	3.65

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CG Oncology Financial Statements

What was CG Oncology's revenue in fiscal 2025?

CG Oncology reported revenue of $4.04M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 254.7% from $1.14M a year earlier.

Is CG Oncology profitable?

No. CG Oncology reported a net loss of $161.00M in fiscal 2025. In fiscal 2024 it lost $88.04M.

What is CG Oncology's operating margin?

CG Oncology's operating income was −$190.77M on revenue of $4.04M in fiscal 2025, an operating margin of -4722.1%, compared with -10067.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition